See All Slides - tctmd.com

Slides

Presentation TCT 2013

Prognostic Implications of Quantitative Ischemia in Stable Ischemic Heart Disease: Lessons from SPECT, PET, and FFR

Presenter: Leslee Shaw

October 28, 2013

Presentation TCT 2013

Anticoagulation and Antiplatelet Regimens After TAVR: Bivalirudin (BRAVO 2/3 Trial) and Other Alternatives

Presenter: George Dangas

October 28, 2013

Presentation TCT 2013

Case Examples(6)

Presenter: Ted Feldman

October 28, 2013

Presentation TCT 2013

Institutional Benefits of a CTO Program

Presenter: James Hermiller Jr

October 28, 2013

Presentation TCT 2013

Editorial Comment: LAA Exclusion: Anatomical Considerations, Device Selection and Outcomes

Presenter: Juan Granada

October 28, 2013

Presentation TCT 2013

Yes! With Current DES and Pharmacotherapy, SYNTAX Is Already Obsolete and the Majority of Patients with MVD Can Be Managed with PCI

Presenter: Dean Kereiakes

October 28, 2013

Presentation TCT 2013

First Look: The MitrAssist Transcatheter Mitral Valve

Presenter: Peter Fitzgerald

October 28, 2013

Presentation TCT 2013

Managing Carotid Stent Complications

Presenter: Leo Nelson Hopkins

October 28, 2013

Presentation TCT 2013

Perspectives on the Role of Primary and Secondary Mitral Regurgitation in Heart Failure: Diagnosis and Management Algorithms

Presenter: Jeffrey Borer

October 28, 2013

Presentation TCT 2013

Do I Really Need Bioresorbable Scaffolds in Germany?

Presenter: Bernhard Witzenbichler

October 28, 2013

Advertisement

Slides

Prognostic Implications of Quantitative Ischemia in Stable Ischemic Heart Disease: Lessons from SPECT, PET, and FFR

Anticoagulation and Antiplatelet Regimens After TAVR: Bivalirudin (BRAVO 2/3 Trial) and Other Alternatives

Case Examples(6)

Institutional Benefits of a CTO Program

Editorial Comment: LAA Exclusion: Anatomical Considerations, Device Selection and Outcomes

Yes! With Current DES and Pharmacotherapy, SYNTAX Is Already Obsolete and the Majority of Patients with MVD Can Be Managed with PCI

First Look: The MitrAssist Transcatheter Mitral Valve

Managing Carotid Stent Complications

Perspectives on the Role of Primary and Secondary Mitral Regurgitation in Heart Failure: Diagnosis and Management Algorithms

Do I Really Need Bioresorbable Scaffolds in Germany?

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content